Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-03

Clinical Trial Update: Prazosin Vibrostimulation Autonomic Dysreflexia and Spinal Cord Injury Study [NA]

View source ↗

Summary

A completed clinical trial evaluating prazosin for autonomic dysreflexia in individuals with spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prazosin (prazosin)

Snippet

Sponsor: University of British Columbia | Conditions: Autonomic Dysreflexia | NA | Status: COMPLETED